Revision: The “Top 100” Drug Interactions for MRCP Part 1

Crack Medicine
7 hours ago
4 min read

TL;DR:

The Top 100 Drug Interactions are among the most frequently examined pharmacology topics in MRCP Part 1. Candidates are expected to recognise dangerous combinations involving warfarin, statins, digoxin, anti-epileptics and QT-prolonging medications. This guide covers the highest-yield interaction patterns, common traps, a practical MCQ and revision strategies to help you score efficiently in pharmacology questions.

Why Drug Interactions Matter in MRCP Part 1

Drug interactions are clinically significant because they contribute substantially to adverse drug events in hospital medicine. In the MRCP examination, they are popular because they test:

Applied pharmacology
Therapeutic safety
Prescribing judgement
Adverse effect recognition
Mechanism-based reasoning

Most interaction questions appear in one of five ways:

Unexpected bleeding
Arrhythmia or prolonged QT interval
Drug toxicity
Sudden biochemical abnormalities
Failure of treatment after adding another medication

The exam rarely asks candidates to simply “name the interaction”. Instead, the interaction is embedded within a clinical scenario.

The Five Most Tested Drug Interaction Themes

1. Warfarin Interactions

Warfarin remains one of the highest-yield drugs in MRCP pharmacology.

Drugs that increase INR

Drug/Class	Mechanism	Consequence
Metronidazole	CYP2C9 inhibition	Markedly raised INR
Clarithromycin	CYP inhibition	Increased bleeding
Fluconazole	CYP inhibition	Severe anticoagulation
Amiodarone	Reduced metabolism	Increased INR
Co-trimoxazole	Protein binding + CYP inhibition	Bleeding risk

Drugs that reduce INR

Rifampicin
Carbamazepine
Phenytoin
St John’s Wort

Exam pearl

An elderly patient stabilised on warfarin who suddenly develops bruising or bleeding after starting antibiotics should immediately raise suspicion of a CYP inhibitor interaction.

2. QT Prolongation Interactions

QT prolongation is increasingly examined in MRCP-style ECG and pharmacology questions.

High-risk combinations

Macrolides + antipsychotics
Fluoroquinolones + amiodarone
Methadone + SSRIs
Ondansetron + antiarrhythmics
Tricyclic antidepressants + electrolyte abnormalities

Typical clues

Syncope
Palpitations
Polymorphic ventricular tachycardia
Hypokalaemia
Prolonged QTc on ECG

Key revision point

Whenever a question combines:

vomiting or diarrhoea,
electrolyte disturbance,
and QT-prolonging drugs,

consider torsades de pointes immediately.

3. Statin Interactions

Simvastatin interactions are classic MRCP favourites.

Important interacting drugs

Drug	Clinical Effect
Clarithromycin	Increased statin levels
Verapamil	Increased myopathy risk
Diltiazem	Rhabdomyolysis
Ciclosporin	Severe toxicity
Azole antifungals	CYP3A4 inhibition

Typical presentation

Muscle pain
Dark urine
Acute kidney injury
Raised creatine kinase

High-yield association

Simvastatin + clarithromycin is one of the most recognisable interaction combinations in MRCP pharmacology.

4. Digoxin Toxicity Interactions

Digoxin remains highly examinable because toxicity presents with multisystem features.

Common precipitating drugs

Amiodarone
Verapamil
Clarithromycin
Quinidine

Clinical features

Nausea
Bradycardia
Confusion
Yellow-green visual disturbance
Hyperkalaemia

Mechanism

Most interactions occur through:

reduced renal clearance,
electrolyte imbalance,
or P-glycoprotein inhibition.

5. Anti-Epileptic Drug Interactions

Anti-epileptic drugs are important because many are hepatic enzyme inducers.

Enzyme-inducing drugs

Carbamazepine
Phenytoin
Phenobarbital

Consequences

Reduced efficacy of:

oral contraceptives,
DOACs,
corticosteroids,
warfarin,
and antiretroviral drugs.

Sodium valproate

Valproate inhibits hepatic metabolism and may increase:

lamotrigine toxicity,
bleeding risk,
and warfarin effect.

Medical student revising clinical pharmacology and drug interactions for MRCP Part 1

The 10 Highest-Yield Drug Interactions to Memorise

Learn these first

Warfarin + metronidazole → raised INR
Simvastatin + clarithromycin → rhabdomyolysis
ACE inhibitor + spironolactone → hyperkalaemia
Digoxin + amiodarone → digoxin toxicity
Sildenafil + nitrates → profound hypotension
SSRIs + MAO inhibitors → serotonin syndrome
Lithium + thiazides → lithium toxicity
Methotrexate + trimethoprim → bone marrow suppression
Macrolides + antipsychotics → QT prolongation
Rifampicin + oral contraceptive → contraceptive failure

These patterns repeatedly appear in:

MRCP revision banks,
prescribing safety questions,
and acute medicine scenarios.

CYP450: The Most Important Mechanism

Understanding CYP450 metabolism simplifies most drug interaction questions.

CYP450 inhibitors

These increase drug levels.

Common inhibitors

Macrolides
Azole antifungals
Amiodarone
Verapamil
Diltiazem

CYP450 inducers

These reduce drug levels.

Common inducers

Rifampicin
Carbamazepine
Phenytoin
Chronic alcohol use

Memory tip

“CRAP GPS” is a popular mnemonic for enzyme inducers:

Carbamazepine
Rifampicin
Alcohol (chronic)
Phenytoin
Griseofulvin
Phenobarbital
Sulfonylureas

Practical Mini-Case

A 74-year-old man with atrial fibrillation is stable on warfarin therapy. He develops abdominal pain and receives metronidazole for presumed diverticulitis. Three days later he presents with haematuria and epistaxis. INR is 8.5.

What is the mechanism?

Answer: CYP450 inhibition reducing warfarin metabolism.

Why this matters for MRCP Part 1

This classic question tests:

pharmacokinetics,
adverse drug reactions,
anticoagulant safety,
and prescribing awareness.

MRCP-Style MCQ

A 67-year-old woman taking simvastatin presents with severe muscle pain and dark urine 5 days after treatment for community-acquired pneumonia. Which antibiotic is most likely responsible?

A. AmoxicillinB. DoxycyclineC. ClarithromycinD. CefalexinE. Co-amoxiclav

Answer: C. Clarithromycin

Explanation

Clarithromycin inhibits CYP3A4 metabolism of simvastatin, markedly increasing statin concentration and risk of rhabdomyolysis. Older patients are particularly vulnerable.

Practical Study-Tip Checklist

How to revise drug interactions efficiently

Use this checklist during revision:

Learn interaction patterns, not isolated facts
Focus first on:
- warfarin,
- statins,
- digoxin,
- anti-epileptics,
- antidepressants
Memorise enzyme inhibitors separately from inducers
Create flashcards for dangerous combinations
Revise electrolyte abnormalities alongside pharmacology
Practise ECG-based QT prolongation questions
Use spaced repetition for high-risk combinations
Reinforce learning with the <a href="https://www.crackmedicine.com/qbank/" target="_blank" rel="noopener noreferrer">MRCP QBank</a>
Consolidate weak areas using <a href="https://www.crackmedicine.com/lectures/" target="_blank" rel="noopener noreferrer">MRCP revision lectures</a>

Common Pitfalls

Five traps candidates frequently miss

Forgetting rifampicin is a potent enzyme inducer
Missing serotonin syndrome clues in antidepressant questions
Overlooking electrolyte abnormalities worsening QT prolongation
Confusing digoxin toxicity with gastroenteritis
Assuming all antibiotics affect warfarin equally

FAQs

Which drug interactions are most important for MRCP Part 1?

Warfarin interactions, statin toxicity, digoxin toxicity, QT prolongation and CYP450 induction/inhibition are the most repeatedly tested areas.

How should I memorise drug interactions for MRCP?

Focus on patterns and mechanisms rather than isolated combinations. Group drugs into enzyme inhibitors, enzyme inducers and high-risk toxicity pairs.

Are CYP450 interactions heavily tested in MRCP Part 1?

Yes. Many pharmacology questions depend on recognising whether a drug increases or decreases hepatic metabolism.

Which antibiotics commonly appear in interaction questions?

Macrolides, rifampicin, metronidazole and co-trimoxazole are especially important because they significantly alter drug metabolism or toxicity.

Is serotonin syndrome examined in MRCP Part 1?

Frequently. Candidates should recognise agitation, hyperreflexia, clonus and hyperthermia in patients taking serotonergic medications.

Ready to start?

Drug interactions remain one of the most efficient pharmacology topics to revise for MRCP because the same high-yield combinations appear repeatedly across question banks and clinical scenarios. Prioritising mechanisms, especially CYP450 effects and QT prolongation risk, allows rapid recognition under exam pressure.

To continue your revision:

Explore the <a href="https://www.crackmedicine.com/mrcp-part-1/" target="_blank" rel="noopener noreferrer">MRCP Part 1 hub</a>
Practise with the <a href="https://www.crackmedicine.com/qbank/" target="_blank" rel="noopener noreferrer">Free MRCP QBank</a>
Strengthen weak topics using the <a href="https://www.crackmedicine.com/lectures/" target="_blank" rel="noopener noreferrer">MRCP lecture series</a>

Sources

MRCP(UK) Examination Blueprint

https://www.mrcpuk.org/mrcpuk-examinations/part-1/preparing-part-1
British National Formulary (BNF)

https://bnf.nice.org.uk/
NICE Medicines Optimisation Guidance

https://www.nice.org.uk/guidance/ng5
Joint Formulary Committee. BNF Online

https://bnf.nice.org.uk/
General Medical Council Prescribing Guidance

https://www.gmc-uk.org/ethical-guidance/ethical-guidance-for-doctors/good-practice-in